$4.510
-0.050 (-1.10%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de ATHE por análisis de gráficos similares
Alphio's ATHE stock price prediction model matches the current Alterity Therapeutics Limited tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-week path is $4.47 (-0.83%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Alterity Therapeutics Limited?
Alterity Therapeutics is a good buy right now due to its recent positive FDA feedback for ATH434, which supports its Phase 3 program, and the stock's current price of $4.51 is significantly lower than the analyst price targets, indicating potential upside. The RSI is at 44.707, suggesting the stock is not overbought, and the 20-day change is +2.15%, indicating a recent positive trend. However, the main risk is the negative earnings report which caused a 4.6% drop in market price.
ATHE cerró en $4.51 el Friday, tras bajar -1.10%
Alterity Therapeutics Limited (ATHE) last closed at $4.51, losing -1.10%. These facts feed the 1-day and 1-week ATHE price prediction above.
Factores de la previsión
Los factores de la previsión de Alterity Therapeutics Limited (ATHE) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de ATHE, ordenadas por similitud.
Análisis de estacionalidad de ATHE
Historically the probability of a positive August return for ATHE is 65.08%. June offers the highest probability of a positive month at 68.33%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de ATHE
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $4.60 | $5.49 | $5.59 | +21.82% |
| Sep 2026 | $5.69 | $6.04 | $6.76 | +33.87% |
| Oct 2026 | $4.20 | $4.88 | $5.44 | +8.16% |
| Nov 2026 | $4.99 | $5.39 | $6.43 | +19.45% |
| Dec 2026 | $4.13 | $4.94 | $5.55 | +9.62% |
En 2026, se proyecta que Alterity Therapeutics Limited (ATHE) oscile entre $4.13 y $6.76.
Previsión mensual de Alterity Therapeutics Limited para 2026
En Aug de 2026, se proyecta que Alterity Therapeutics Limited promedie $5.49, con un mínimo de $4.60 y un máximo de $5.59.
En Sep de 2026, se proyecta que Alterity Therapeutics Limited promedie $6.04, con un mínimo de $5.69 y un máximo de $6.76.
En Oct de 2026, se proyecta que Alterity Therapeutics Limited promedie $4.88, con un mínimo de $4.20 y un máximo de $5.44.
En Nov de 2026, se proyecta que Alterity Therapeutics Limited promedie $5.39, con un mínimo de $4.99 y un máximo de $6.43.
En Dec de 2026, se proyecta que Alterity Therapeutics Limited promedie $4.94, con un mínimo de $4.13 y un máximo de $5.55.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.